FDA Inspection 1167531 — Innovative Blood Resources, A Division of New York Blood Center Inc
The FDA completed an inspection of Innovative Blood Resources, A Division of New York Blood Center Inc on March 24, 2022 in Coon Rapids, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 24, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Coon Rapids, MN (United States)